Michael Tscheppe is Chief Financial Officer at Nuvonis. Michael, please explain your role roughly.
I’m responsible for budget, finance, and the whole trading business. One of my main tasks is elaborating the contracts with our partners and customers. I have a classical economic background and over 20 years of experience in the biotech industry. The crucial question in my field of activity is: How do I invest our resources in the best possible way. I would characterize my role also as „interpreter“ between the various stakeholders and our investors.
What was the most successful experience with Nuvonis so far?
We won a deal for developing a cell bank for an international vaccine company. The most challenging experience was to support the customer within the sales cycle and to show them how partnering with Nuvonis would make them faster, reduce their risk and taking advantage out of working with us. Our goal is to prevent our partners from losing time and money.
What are the main advantages of Nuvonis?
We do not just offer cell banks but a powerful knowledge bundle. Apart from the product itself, our customers get a detailed report and checklist on how to handle a cell bank. Our process development is outstanding. I’m sure we are ready to shape the future of the biotech industry.
What do you love most about working for Nuvonis?
I enjoy the company of my highly skilled colleagues. We put our competences and our energy together to make sure our customers do not have to go through the same learning curve we had to over the years. Nuvonis stands for an ambitious project and a great technology.